MedPath

Treatment of Giardiasis with Praziquantel or Mebendazole

Phase 3
Conditions
giardiasis.
Giardiasis [lambliasis]
Registration Number
IRCT138708131431N1
Lead Sponsor
Shahrekord university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
600
Inclusion Criteria

Patients with gastrointestinal complaints including diarrhea; weight loss; anorexia or fatigue and positive for Giardaisis. Exclusion criteria: Drug side effects; Immune deficiency; consumption of current antibiotic.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Treatment of giardiasis. Timepoint: 7-10 dayes after treatment. Method of measurement: stool examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath